145 related articles for article (PubMed ID: 3485476)
21. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
22. A serum independent medium effective in all aspects of hybridoma technology and immunological applications.
Baker P; Knoblock K; Noll L; Wyatt D; Lydersen B
Dev Biol Stand; 1985; 60():63-72. PubMed ID: 3876250
[TBL] [Abstract][Full Text] [Related]
23. The WI-L2-729-HF2 human hybridoma system. Stable hybrids at high frequency.
Heitzmann JG; Cohn M
Mol Biol Med; 1983 Sep; 1(2):235-43. PubMed ID: 6334216
[TBL] [Abstract][Full Text] [Related]
24. Estimation of heterokaryon formation and hybridoma growth in murine and human cell fusions.
Alkan SS; Mestel F; Jiricka J; Blaser K
Hybridoma; 1987 Aug; 6(4):371-9. PubMed ID: 3623581
[TBL] [Abstract][Full Text] [Related]
25. CD19+ B lymphocytes are the major source of human antibody-secreting hybridomas generated by electrofusion.
Schmidt E; Leinfelder U; Gessner P; Zillikens D; Bröcker EB; Zimmermann U
J Immunol Methods; 2001 Sep; 255(1-2):93-102. PubMed ID: 11470290
[TBL] [Abstract][Full Text] [Related]
26. Antibody producing human-human hybridomas. I. Technical aspects.
Olsson L; Kronstrøm H; Cambon-De Mouzon A; Honsik C; Brodin T; Jakobsen B
J Immunol Methods; 1983 Jun; 61(1):17-32. PubMed ID: 6343505
[TBL] [Abstract][Full Text] [Related]
27. The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus.
Grunow R; Jahn S; Porstmann T; Kiessig SS; Steinkellner H; Steindl F; Mattanovich D; Gürtler L; Deinhardt F; Katinger H
J Immunol Methods; 1988 Feb; 106(2):257-65. PubMed ID: 2828478
[TBL] [Abstract][Full Text] [Related]
28. Generation of human monoclonal antibodies reactive with cellular antigens.
Cote RJ; Morrissey DM; Houghton AN; Beattie EJ; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1983 Apr; 80(7):2026-30. PubMed ID: 6572959
[TBL] [Abstract][Full Text] [Related]
29. A strategy for the production of human monoclonal antibodies reactive with lung tumor cell lines.
Cole SP; Campling BG; Louwman IH; Kozbor D; Roder JC
Cancer Res; 1984 Jul; 44(7):2750-3. PubMed ID: 6327024
[TBL] [Abstract][Full Text] [Related]
30. Polyethylene Glycol Fusion for Hybridoma Production.
Greenfield EA
Cold Spring Harb Protoc; 2018 Mar; 2018(3):. PubMed ID: 29496822
[TBL] [Abstract][Full Text] [Related]
31. A microfluidic approach towards hybridoma generation for cancer immunotherapy.
Lu YT; Pendharkar GP; Lu CH; Chang CM; Liu CH
Oncotarget; 2015 Nov; 6(36):38764-76. PubMed ID: 26462149
[TBL] [Abstract][Full Text] [Related]
32. Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.
Houghton AN; Brooks H; Cote RJ; Taormina MC; Oettgen HF; Old LJ
J Exp Med; 1983 Jul; 158(1):53-65. PubMed ID: 6864164
[TBL] [Abstract][Full Text] [Related]
33. Increase of hybridoma formation by human lymphocytes after stimulation in vitro; effect of antigen, endothelial cells, and PWM.
Astaldi GC; Wright EP; Willems C; Zeijlemaker WP; Janssen MC
J Immunol; 1982 Jun; 128(6):2539-42. PubMed ID: 6804563
[TBL] [Abstract][Full Text] [Related]
34. Electro Cell Fusion for Hybridoma Production.
Greenfield EA
Cold Spring Harb Protoc; 2019 Oct; 2019(10):. PubMed ID: 31575798
[TBL] [Abstract][Full Text] [Related]
35. Comparison of three human-murine heteromyeloma cell lines for formation of human hybridomas after electrofusion with human peripheral blood lymphocytes from meningococcal cases and carriers.
Delvig AA; Koumaré B; Glaser RW; Wang JF; Jahn S; Achtman M
Hum Antibodies Hybridomas; 1995; 6(2):42-6. PubMed ID: 7492749
[TBL] [Abstract][Full Text] [Related]
36. Generation of a fusion partner to sample the repertoire of splenic B cells destined for apoptosis.
Ray S; Diamond B
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5548-51. PubMed ID: 8202525
[TBL] [Abstract][Full Text] [Related]
37. Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.
Chiorazzi N; Wasserman RL; Kunkel HG
J Exp Med; 1982 Sep; 156(3):930-5. PubMed ID: 6286839
[TBL] [Abstract][Full Text] [Related]
38. A new method for the development of human T-T cell hybrids without the use of HAT medium.
Platsoucas CD; Calvelli TA; Kunicka JA
Hybridoma; 1987 Dec; 6(6):589-603. PubMed ID: 3501764
[TBL] [Abstract][Full Text] [Related]
39. Improved fusion partners transfected with DNA fragment encoding IL-11 on generation of human B lymphocyte hybridomas.
Zhu Y; Jin B; Jiang S; Sun K; Sun C; Liu X
Hum Antibodies; 1999; 9(1):1-7. PubMed ID: 10331181
[TBL] [Abstract][Full Text] [Related]
40. [Effect of lymphokines produced by human T-T hybridomas on the proliferation of normal and neoplastic B lymphocytes].
Gambatesa V
Medicina (Firenze); 1989; 9(2):184-7. PubMed ID: 2811645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
